JP2011517448A - ベンゾ−融合ダイオキシン誘導体の調製プロセス - Google Patents

ベンゾ−融合ダイオキシン誘導体の調製プロセス Download PDF

Info

Publication number
JP2011517448A
JP2011517448A JP2011501762A JP2011501762A JP2011517448A JP 2011517448 A JP2011517448 A JP 2011517448A JP 2011501762 A JP2011501762 A JP 2011501762A JP 2011501762 A JP2011501762 A JP 2011501762A JP 2011517448 A JP2011517448 A JP 2011517448A
Authority
JP
Japan
Prior art keywords
formula
compound
group
reacting
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011501762A
Other languages
English (en)
Japanese (ja)
Inventor
バレンタイン，スコツト・エイ
リーニイ，ローラ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of JP2011517448A publication Critical patent/JP2011517448A/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
JP2011501762A 2008-03-26 2008-03-26 ベンゾ−融合ダイオキシン誘導体の調製プロセス Withdrawn JP2011517448A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2008/058247 WO2009120192A2 (en) 2008-03-26 2008-03-26 Process for the preparation of benzo-fused heteroaryl derivatives

Publications (1)

Publication Number Publication Date
JP2011517448A true JP2011517448A (ja) 2011-06-09

Family

ID=40351717

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011501762A Withdrawn JP2011517448A (ja) 2008-03-26 2008-03-26 ベンゾ−融合ダイオキシン誘導体の調製プロセス

Country Status (13)

Country Link
EP (1) EP2280951A2 (es)
JP (1) JP2011517448A (es)
KR (1) KR20100126536A (es)
CN (1) CN101981023A (es)
AU (1) AU2008353492A1 (es)
BR (1) BRPI0822396A2 (es)
CA (1) CA2719402A1 (es)
EA (1) EA201071121A1 (es)
EC (1) ECSP10010498A (es)
IL (1) IL208223A0 (es)
MX (1) MX2010010597A (es)
WO (1) WO2009120192A2 (es)
ZA (1) ZA201007610B (es)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014528399A (ja) * 2011-09-29 2014-10-27 ヤンセン ファーマシューティカ エヌ．ベー． スルファミド誘導体の改善された調製プロセス
JP2014528953A (ja) * 2011-09-29 2014-10-30 ヤンセン ファーマシューティカ エヌ．ベー． スルファミド誘導体の調製プロセス

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY147767A (en) 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
JP2008545650A (ja) 2005-05-20 2008-12-18 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ スルファミド誘導体の製造方法
US8937096B2 (en) 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US8497298B2 (en) 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US8691867B2 (en) 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
EP2026790A2 (en) 2006-05-19 2009-02-25 Janssen Pharmaceutica, N.V. Co-therapy for the treatment of epilepsy and related disorders
AU2009271362B2 (en) 2008-06-23 2014-03-13 Janssen Pharmaceutica Nv Crystalline form of (2s)-(-)-N-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide
US8815939B2 (en) 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120758A (en) * 1991-02-08 1992-06-09 Ciba-Geigy Corporation Certain benzodioxole, benzodioxane and benzodioxepin derivatives useful as 5-lipoxygenase inhibitors
MY147767A (en) * 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014528399A (ja) * 2011-09-29 2014-10-27 ヤンセン ファーマシューティカ エヌ．ベー． スルファミド誘導体の改善された調製プロセス
JP2014528953A (ja) * 2011-09-29 2014-10-30 ヤンセン ファーマシューティカ エヌ．ベー． スルファミド誘導体の調製プロセス

Also Published As

Publication number Publication date
ZA201007610B (en) 2012-04-25
BRPI0822396A2 (pt) 2019-09-24
MX2010010597A (es) 2010-10-25
CA2719402A1 (en) 2009-10-01
WO2009120192A2 (en) 2009-10-01
EA201071121A1 (ru) 2011-04-29
ECSP10010498A (es) 2010-10-30
WO2009120192A3 (en) 2010-01-21
EP2280951A2 (en) 2011-02-09
AU2008353492A1 (en) 2009-10-01
KR20100126536A (ko) 2010-12-01
IL208223A0 (en) 2010-12-30
CN101981023A (zh) 2011-02-23

Similar Documents

Publication Publication Date Title
JP2011517448A (ja) ベンゾ−融合ダイオキシン誘導体の調製プロセス
US20090247618A1 (en) Process for preparation of benzo-fused heteroaryl derivatives
JP5416740B2 (ja) てんかんおよび関連疾患を治療するためのスルファメートおよびスルファミド誘導体
JP2011515464A (ja) ベンゾ縮合されたヘテロアリールスルファマート及びｎ−（（（２ｓ）−６−クロロ−２，３−ジヒドロ−ｌ，４−ベンゾジオキシン−２イル）メチル−スルファミドの調製プロセス
US20090247617A1 (en) Process for the preparation of benzo-fused heteroaryl sulfamates
US20090182141A1 (en) Process for the preparation of sulfamide derivatives
JP2008503488A (ja) てんかんおよび関連疾患を治療するためのスルファメートおよびスルファミド誘導体
SK175398A3 (en) Spiro-piperidine derivatives and their use as therapeutic agents
JP2009509928A (ja) カリウムチャンネル開口剤としての新規ベンゾピラン誘導体
JP2011529056A (ja) 新規な置換スルファミド誘導体
CN112041296B (zh) 包含苯并含氧脂肪环结构的氨基乙酰胺类化合物及其用途
BR112020018983A2 (pt) Inibidores de canal receptor de potencial transitório de oxadiazol
BR112012032813B1 (pt) Composto heterocíclico de benzodioxol ou benzodioxepina, composição farmacêutica, e, uso do composto
JPH02290841A (ja) 新規化合物、その製法及びそれを含む医薬組成物
US5206252A (en) Thiadiazolyl-amino derivatives of benzopyrans and indanes
JP2009509927A (ja) カリウムチャンネル開口剤としての新規ベンゾピラン誘導体
JP6736660B2 (ja) 疼痛のための治療化合物及びその合成
KR20140082736A (ko) 설파미드 유도체의 제조 방법
RU2135501C1 (ru) Замещенные дигидропиранопиридины, способ их получения, промежуточные соединения, фармацевтическая композиция и способ ее получения
JP2009532380A (ja) カリウムチャンネルのオープナーとしての３，４−ジアミノ−３−シクロブテン−１，２−ジオン誘導体
KR20140082762A (ko) 설파미드 유도체의 개선된 제조 방법
CN117769545A (zh) 含三并环类衍生物调节剂、其制备方法和应用
KR101198831B1 (ko) 간질 및 연관된 질병의 치료용 설파메이트 및 설파미드유도체
JPS61233684A (ja) 新規なスピロイミダゾリジン−２，５−ジオン誘導体およびその製法
TW200835476A (en) Process for preparation of benzo-fused heteroaryl derivatives

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110323

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20120712